NCT00002143View on ClinicalTrials.gov

Treatment of Psoriasis Using Acitretin in HIV-Positive Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

Not specified

Conditions
HIV InfectionsPsoriasis
Interventions
DRUG

Acitretin

Trial Locations (1)

10003

Beth Israel Med Ctr, New York

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00002143 - Treatment of Psoriasis Using Acitretin in HIV-Positive Patients | Biotech Hunter | Biotech Hunter